Macquarie Group’s ProQR Therapeutics PRQR Stock Holding History

Macquarie Group’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-620,000	Closed	-$1.32M	–	1338
2025 Q3	$1.32M	Hold	620,000	–	–	﹤0.01%	1276
2025 Q2	$1.26M	Hold	620,000	–	–	﹤0.01%	1330
2025 Q1	$825K	Hold	620,000	–	–	﹤0.01%	1414
2024 Q4	$1.64M	Hold	620,000	–	–	﹤0.01%	1254
2024 Q3	$1.13M	Hold	620,000	–	–	﹤0.01%	1355
2024 Q2	$1.03M	Hold	620,000	–	–	﹤0.01%	1374
2024 Q1	$1.41M	Hold	620,000	–	–	﹤0.01%	1312
2023 Q4	$1.23M	Hold	620,000	–	–	﹤0.01%	1339
2023 Q3	$806K	Hold	620,000	–	–	﹤0.01%	1382
2023 Q2	$1M	Hold	620,000	–	–	﹤0.01%	1357
2023 Q1	$1.32M	Hold	620,000	–	–	﹤0.01%	1294
2022 Q4	$2.29M	Hold	620,000	–	–	﹤0.01%	1175
2022 Q3	$461K	Hold	620,000	–	–	﹤0.01%	1538
2022 Q2	$482K	Hold	620,000	–	–	﹤0.01%	1592
2022 Q1	$561K	Hold	620,000	–	–	﹤0.01%	1630
2021 Q4	$4.97M	Hold	620,000	–	–	﹤0.01%	1120
2021 Q3	$5.19M	Hold	620,000	–	–	﹤0.01%	1099
2021 Q2	$4.18M	Hold	620,000	–	–	﹤0.01%	1180
2021 Q1	$4.1M	Buy	+620,000	New	+$3.17M	0.01%	963
2018 Q1	–	Sell	-2,900	Closed	-$9K	–	2325
2017 Q4	$9K	Buy	+2,900	New	+$10.4K	﹤0.01%	2279

Other funds holding PRQR

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Macquarie Group's PRQR Position: Q4 2025 in Review

Macquarie Group sold out of ProQR Therapeutics (PRQR) in Q4 2025, closing a stake of 620,000 shares — an estimated $1.32M sold.

Macquarie Group first reported a position in PRQR in Q4 2017 and held it in 20 quarters. The position peaked at $5.19M in Q3 2021. 65 funds tracked by Wall St. Rank hold PRQR as of Q4 2025.

Macquarie Group reported no remaining ProQR Therapeutics position as of Q4 2025 after selling out during the quarter.
Macquarie Group sold 620,000 ProQR Therapeutics shares in Q4 2025, an estimated $1.32M.
Macquarie Group first reported a position in ProQR Therapeutics in Q4 2017 and held it in 20 quarters.
Macquarie Group's ProQR Therapeutics position peaked at $5.19M in Q3 2021.
65 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.